@VedangMurthy

Professor GU-Radiation Oncology, Tata Memorial Centre Mumbai. Marathoner. Just turned triathlete.

 Mumbai
Joined November 2020
  • Tweets2.7K
  • Following94
  • Followers3.3K
207Media
Some moments in any academic life are defining... One near the top is being invited to deliver the visiting prof grand rounds to the bright and curious minds of the @HarvardRadOnc residents! Showered with love and warmth Hope you enjoyed as much as I did. 🙏🏼 @DrPaulNguyen
TMC Radiation Oncology@RadOncTMCOct 1
Our faculty, @VedangMurthy, was invited as a Visiting Professor by the @HarvardRadOnc, where he spoke on “Radiotherapy for Urological Cancers: Asking the Right Questions.” We congratulate Dr. Murthy on this recognition & contribution to the global academic dialogue!
22
17
4
211
8,026
Vedang Murthy retweeted
Vedang Murthy@VedangMurthyOct 17
Replying to @CanesDavid
TBH I am not blaming the AI at all! It does what it does. I speak from the audience's POV. Steering it to make it beautiful and meaningful (for the listener) needs much more time and effort than making it the good old fashioned way! The irony of it! 😀
1
1
7
736
Vedang Murthy retweeted
Vedang Murthy@VedangMurthyOct 16
Replying to @StrijbosMichiel @TylerSbrt @piet_ost
I actually don't blame the AI in this case...
1
1
1
510
AI-generated slides have taken over every conference.😴 Boxes inside boxes, microscopic text, arrows connecting everything to everything else The message is hidden deeper than a pelvic node! Quite a turn-off. We need a pre-conference workshop just to read the slides.
22
27
4
223
16,605
Vedang Murthy retweeted
Raquibul Hannan@Raquib_HannanOct 15
Excited to share our JAMA Oncology phase 2 trial of neoadjuvant SAbR for RCC with IVC tumor thrombus! 1-year RFS: 71.4%, meeting the prespecified criterion. Feasible with encouraging safety findings. Larger trials are next! doi.org/10.1001/jamaoncol.20… #KidneyCancer #RadOnc
3
18
54
2,813
We are excited to announce a new strategic partnership between the GSRGT and Urology Times! Together, we aim to advance education, share expert insights, and raise awareness of rare GU malignancies. Stay tuned for more! @SpiessPhilippe @drgaganprakash @npaesa @CMercinelli @AmerUrological @CAU_URO @JadChahoud @benristau @PGrivasMDPhD @spsutkaMD @LuisMedinaMD @herneygarcia @AndreaNecchi @apolo_andrea @VedangMurthy @ARRODRIGUEZMD @montypal @UrogerliMD @dramandeeparora @CurtisPettaway1 @karima_oualla @UrologyTimes
1
8
2
21
1,597
Colleagues, The abstract submission deadline for 2027 ASCO GU Symposium is October 13 at 11:59 pm ET. #GU27 Our committee looks forward to reviewing your work! All accepted abstracts will be published in the JCO supplement.@ASCO_pubs Submit today: asco.confex.com/asco/gucs202…
6
21
1,178
Heartiest congratulations @VedangMurthy ! Incredibly proud to work with you.
Vedang Murthy@VedangMurthyOct 2
Some moments in any academic life are defining... One near the top is being invited to deliver the visiting prof grand rounds to the bright and curious minds of the @HarvardRadOnc residents! Showered with love and warmth Hope you enjoyed as much as I did. 🙏🏼 @DrPaulNguyen
1
1
180
Capping off #ASTRO26 week with an HROP first! 🌎☢️ We were thrilled to welcome Professor @VedangMurthy as our 1st international visiting professor. A great way to close out a week of learning & collaboration in Boston. Thank you for visiting and sharing your expertise with us!
2
11
1
89
2,530
Vedang Murthy retweeted
Tyler Seibert MD PhD@TylerSbrtSep 29
Replying to @VedangMurthy
@VedangMurthy with secondary analysis of POP-RT using Artera MMAI. Intriguing results suggesting digital pathology + clinical variables could stratify risk of occult LN metastasis and benefit of pelvic RT @ASTRO_org #ASTRO26
2
13
36
1,191
This review, led by @DeepOnco of @royalmarsdenNHS, outlines global trends and the evolving diagnostics, treatment, and surveillance of #ProstateCancer: acsjournals.onlinelibrary.wi… @PCaParker @AmarUKishan @VedangMurthy @nickva1 @alison_tree @APCCC_Lugano @ICR_London #PCAM
4
8
1,271
Vedang Murthy retweeted
Simon C
@scserendipity1Sep 12
Replying to @piet_ost @VedangMurthy @ProtonStorey
🇧🇪✨ Morning Piet! I came here for an answer not for your Belgium beautifully balanced intellect. Would you start now? And if so what? And in most cases we could wait if the patient agrees, and it’s a stressful time for time, but as you know some people do develop symptomatic disease that can cause long term morbidity. I would treat now and in this case with ADT and Enza (if patient in agreement) with recommended exercise and diet @Adam_Weiner535 (excellent post yesterday) and aim for intermittent therapy if a good response. Hope all well
1
1
1
341
Vedang Murthy retweeted
Piet Ost@piet_ostSep 12
Replying to @VedangMurthy @ProtonStorey @scserendipity1
The fast DT and high absolute PSA level without macroscopic disease can be monitored in this asymptomatic patient, but within 6 to 12mo the mets will show up and he will require systemic Tx. We still don’t know the ideal timing of starting.
1
1
6
435
Replying to @piet_ost @VedangMurthy
What is T? My guess is diffuse marrow disease rather than nodal. Have seen this once before. Repeat PSMA PET after 4 wks of ARPI capitalising PSMA flare could be an option. Either ways not taking systemic therapy is not an option for long.
1
1
3
408
Vedang Murthy retweeted
Nicholas van As@nickva1Sep 11
Please see our letter @alison_tree @piet_ost in response to the recent Focal therapy paper in @EUplatinum authors.elsevier.com/a/1nlq2… @LondonProstate1 @mrsprostate @taimurShah @ASTRO_org @ESTRO_RT
4
29
6
67
17,975
#PSMA Case Conundrum 65y HR #prostatecancer, cT3a, iPSA-55.68, GS:5+4 SBRT 2018 36.25Gy+ 2y ADT 2020 (no Abi) BCF + Local rec (Bx:GG4) 2024; ReSBRT done PSA Rising again12....24...60! All PSMA and FDG PET are -ve No Symptoms Why wont PSMA/FDG light up? Now what? Thoughts?
12
5
3
30
6,771
@TylerSbrt @alison_tree @piet_ost @ZilliThomas @PaulSargos @DrPaulNguyen @HimanshuNagarMD @CZamboglou @SbrtSean @DrMHofman @drlouiseemmett @ProfKHerrmann
333
Great show Archya and all the students!
Archya Dasgupta@ArchyaDasguptaSep 6
Excellent show by @RadOncTMC residents in PTCOG Asia Oceania conference presenting multiple data from Proton Therapy Centre @ACTREC_TMC @TataMemorial Dr Siddharth wining the best clinical paper award and travel awards (Drs Sunidhi, Avani, Manjari) @VedangMurthy @PTCOG_Official
12
1,321
Long-term Oncological Outcomes of Retzius-sparing Versus Anterior Robot-assisted Radical Prostatectomy: Post Hoc Analysis of a Randomized Cohort by Alfonso Santangelo ...Firas Abdollah et al buff.ly/OZUURYD Thank you to all the authors for trusting EUO to publish your work! @santangelo_alfo @DrFAbdollah @pr.morgan.roupret @ric_campi89 @laura.marandino @jteoh_hk @davdandrea @renu.eapen @uroweb @gu_cast_podcast @oncoalert @elsevier_oncology @elsevier_connect
5
25
7
69
28,226
Load more